Akebia Therapeutics Inc. buy StockNews.com
Start price
20.04.24
/
50%
€1.28
Target price
20.04.25
-
Performance (%)
-20.39%
Price
24.05.24
€1.02
Summary
This prediction is currently active. The price of Akebia Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -20.39%. This prediction currently runs until 20.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | -4.049% | -4.049% |
iShares Core DAX® | -0.205% | 2.949% |
iShares Nasdaq 100 | 1.613% | 5.877% |
iShares Nikkei 225® | -0.740% | -1.256% |
iShares S&P 500 | 0.267% | 3.240% |
Comments by StockNews_com for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for AKBA provided by MarketBeat